Camp4 Therapeutics Corp (CAMP) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CAMP currently has 51.9M outstanding shares. with limited dilution risk as only 5.75M additional shares (11.1%) are authorized for issuance. The company has significantly diluted shareholders by 202.28% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 51.9M shares outstanding |
52M | 5.8M |
| Nov 10, 2025 |
S-3 filing: This S-3 filing outlines the offering of common stock by the company through an "at the market offering" (ATM) on The Nasdaq Global Market, with Leerink Partners as the underwriter. The aggregate offering price is up to $100,000,000, and the company intends to use the net proceeds for general corporate purposes. |
47M | 5.8M |
| Nov 06, 2025 |
10-Q filing | 46.9M shares outstanding |
47M | 5.8M |
| Sep 10, 2025 |
8-K filing: CAMP4 Therapeutics Corporation entered into a Securities Purchase Agreement to sell shares of common stock and pre-funded warrants in a private placement. ($50.07M proceeds) |
20M | 5.8M |
| Aug 14, 2025 |
10-Q filing | 20.2M shares outstanding |
20M | 5.8M |
| May 13, 2025 |
10-Q filing | 20.2M shares outstanding |
20M | 5.8M |
| Mar 27, 2025 |
10-K filing | 20.2M shares outstanding |
20M | 5.8M |
| Nov 21, 2024 |
10-Q filing | 20.2M shares outstanding |
20M | 5.8M |
| Oct 07, 2024 |
S-1/A filing: This is an initial public offering of shares of common stock by CAMP4 Therapeutics Corporation, offering 5,000,000 shares with an expected price between $14.00 and $16.00 per share. |
13M | 5.8M |
| Sep 26, 2024 |
S-1/A filing: This is an initial public offering of shares of common stock by CAMP4 Therapeutics Corporation. |
140M | 0 |
| Sep 20, 2024 |
S-1 filing: This is an initial public offering of shares of common stock by CAMP4 Therapeutics Corporation. |
140M | 0 |